Epalex Corporation logo

Epalex Corporation

Epalex is a startup pharmaceutical company focused upon novel therapeutics which address unmet medical needs in the area of serious neurological diseases, especially migraine and epilepsy.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.epalex.com
Founded2011
Disease Focus
Development Stage
STOCK CODENon Listed
Address
305 Lytton Avenue, CA 094301
Palo Alto
United States
Email
Contact Number
+1 215 882 4674

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/epalex-corporation” connections=”true” suffix=””]

EpaleX is developing a novel inhaled treatment for epilepsy and migraine. When a seizure warning sign (aura) occurs, the patient will be able to prevent the development of a full-blown seizure through the use of a pocket nebulizer to deliver a powerful anti-seizure medication that rapidly enters the brain and stops the seizure. One product (EP-102) for oral treatment for acute migraine and The second product (EP-103) is designed for the treatment for acute repetitive seizures.

Product development is supported by research grants from the Epilepsy Therapy Project, the Epilepsy Foundation & National Institutes of Health through the National Center for Advancing Translational Sciences.